Takeda Establishes Two Subsidiaries In Singapore
This article was originally published in PharmAsia News
Executive Summary
Takeda announced the establishment of two subsidiaries in Singapore Sept. 25 to conduct clinical trials with an initial investment of SGD 5 million. Takeda has conducted fewer clinical trials in Southeast Asia compared to other regions; Takeda Research Singapore will look to expand Takeda's clinical trial presence in the region. Another subsidiary will focus on product marketing and sales. Takeda views Singapore as a hub to connect Japan with Europe and the U.S., as well as with the rest of Asia and Oceania. (Click here for more - Japanese language